Summary. The effects of a single dose of alinidine (0.5 mg/kg i. v.), the N-allyl-derivative of c1onidine, on heart rate and blood pressure were investigated in healthy volunteers and in patients with hyperkinetic heart syndrome, at rest and during bicyc1e exercise. In healthy volunteers plasma catecholamine levels were also determined. Alinidine did not change heart rate at rest in the healthy volunteers but it did signifi cantly reduce exercise-induced tachycardia, whereas blood pressure and plasma catecholamine levels were not significantly affected by alinidine, either at rest or during exercise. In patients with hyperkinetic heart syndrome, alinidine reduced heart rate at rest and during exercise to a similar extent as proprano 101 (0.1 mg/kg i. v.). The blood pressure did not change with alinidine but it was significantly re duced by propranolol. The obserVation that an alini dine-induced reduction of heart rate occurs without a concomitant fall in blood pressure, and without a c1onidine-like symphatho-inhibitory action, is in line with experimental findings suggesting a specific bradycardic action of alinidine under short-term conditions.
A great deal of information about physical adjustment to work can be obtained from quantitative stress testing. Maximal stress limited by symptoms of exertional intolerance is the concept of the 2 min duration work increment test (rectangular-triangular exercise test). Compared to steady-state work tests strict observation of the standardized procedure- and computer assisted evaluation of ergospirometric parameters offer innovatory opportunities: (1) the test is of short duration (8-14 min), (2) the subjects recover rapidly, even from an exhausting test, (3) one is more likely to be able to observe plateauing of VO2, should determination of maximal VO2 be desired, (4) adaptation to increasing work rates and maximal work capacity is assessable, (5) computer technics provide on-line assessment of aerobic and anaerobic power in quantitative terms, (6) measurements proved to be highly reproducible, (7) the relationship between variables such as increments of heart rate and systolic blood pressure, respiratory minute volume, oxygen uptake during the early phase of the non-steady-state condition and the index of anaerobic power, and the influence of factors such as work load and work output, has been studied to derive standard values. Soft-ware programs have been designed to estimate deviation of parameters actually measured from standard values in terms of multiples of the standard deviation of the standard regression line. In particular, evaluating oxygen uptake during short time-intervals (0.5 min) provides information about adequate adaptational forces of the cardio-circulatory system. Energy that is not accounted for by reactions involving the VO2 measured is computed by substracting the caloric equivalent of oxygen uptake during work exceeding the steady-state level during rest from the energy demand to sustain a given work load aerobically. This index of anaerobic power is defined in kcal, cal/kg body wt., and as a percentage of the total amount of energy required (moderately trained athletes 350-500 cal/kg; sedentary people 200-300 cal/kg). A close relationship to parameters of metabolic acidosis (base excess) exists. It is concluded that the physical performance of sedentary people, athletes and patients with impaired cardio-pulmonary function can be more precisely qualified in quantitative terms by means of computer assisted rectangular-triangular ergospirometry. Results obtained in patients with diseased conditions must be carefully interpreted, their condition suggesting the use of more invasive investigations to reveal the pathophysiologic mechanism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.